# Earneka Wiggins v. Hackensack Meridian Health

> Supreme Court of New Jersey · January 22, 2025

URL: https://www.frixlaw.com/law-library/cases/10784949

## Case

- **Court:** Supreme Court of New Jersey
- **Decided:** January 22, 2025
- **Precedential status:** Published
- **Opinion:** Opinion
- **Cited by:** 0 later opinions in the Frix Law Library

## Citator (automated)

- No negative treatment found by the automated citator. That is not the same as a confirmation that the case is good law; read the citing cases.
- Full citator and citing cases: https://www.frixlaw.com/law-library/cases/10784949

## Opinion text

SYLLABUS

This syllabus is not part of the Court’s opinion. It has been prepared by the Office
of the Clerk for the convenience of the reader. It has been neither reviewed nor
approved by the Court and may not summarize all portions of the opinion.

Earneka Wiggins v. Hackensack Meridian Health (A-43-23) (089441)

Argued November 4, 2024 -- Decided January 22, 2025

FASCIALE, J., writing for a unanimous Court.

In this medical malpractice appeal, the legal question is whether plaintiffs’
service of an affidavit of merit (AOM) from a board-certified internal medicine
doctor is sufficient to overcome a motion to dismiss when defendants’ Rule 4:5-3
Specialty Statement states that “[a]t all relevant times, these defendants practiced the
medical specialties of Internal Medicine and Gastroenterology and their treatment of
[the patient] involved the medical specialties of Internal Medicine and
Gastroenterology.”

Plaintiffs, the administrators of the Estate of April Carden, filed a medical
malpractice complaint against defendants Hackensack Meridian Health d/b/a JFK
University Medical Center (JFK), Alok Goyal, M.D., and South Plainfield Primary
Care (SPPC) (collectively, defendants). As relevant here, plaintiffs allege that
Carden’s death was directly attributable to Allopurinol prescribed by Dr. Goyal, that
Dr. Goyal’s negligence caused Carden’s death, and that JFK and SPPC were
vicariously liable because Dr. Goyal was an “agent, servant, or employee” of both.

Dr. Goyal and SPPC filed their answer and included the following Rule 4:5-3
Specialty Statement: “At all relevant times, these defendants practiced the medical
specialties of Internal Medicine and Gastroenterology and their treatment of
[Carden] involved the medical specialties of Internal Medicine and
Gastroenterology.” Plaintiffs provided each defendant with an AOM from Dr. Stella
Jones Fitzgibbons, who is board certified by the American Board of Internal
Medicine. Defendants stated that Dr. Fitzgibbons was unqualified to execute an
AOM as to them. Dr. Goyal amplified his Specialty Statement, noting that “[a]ll
treatment that I rendered to [Carden] was provided as both an internist and as a
gastroenterologist.” Defendants then moved to dismiss the complaint for failure to
comply with the AOM statute. Plaintiffs argued that internists prescribe
Allopurinol, not gastroenterologists. Alternatively, plaintiffs argued that, given
defendants’ Specialty Statement, an AOM from an internist is sufficient.

1
The trial judge denied the motions to dismiss the complaint. He found “that
the ‘care and treatment at issue’ was the prescribing of Allopurinol, and the ‘care or
treatment at issue involves internal [medicine].’” (citing N.J.S.A. 2A:53A-41).
Relying on Buck v. Henry, 207 N.J. 377 (2011), the trial judge concluded
alternatively that plaintiffs complied with the AOM statute by submitting the AOM
from Dr. Fitzgibbons, who is board certified in internal medicine. The judge later
denied defendants’ motion for reconsideration.

The Appellate Division granted defendants’ motion for leave to appeal from
the orders denying their motions to dismiss and for reconsideration and reversed
those orders, concluding that plaintiffs were required to “serve an AOM from a
physician board certified in each of [Dr. Goyal’s] specialties” and that the language
from Buck on which the trial court relied was dicta. 478 N.J. Super. 355, 358, 373
(App. Div. 2024). The Court granted leave to appeal. 258 N.J. 164 (2024).

HELD: When a defending physician practices in more than one specialty and the
treatment involved falls within any of that physician’s specialty areas, then an AOM
from a physician specializing in one of those specialties is sufficient.

1. Under N.J.S.A. 2A:53A-27, a medical malpractice plaintiff must show that the
complaint is meritorious by obtaining an affidavit from “an appropriate licensed
person” attesting to the “reasonable probability” of professional negligence. The
dual purposes of the AOM statute are to weed out frivolous lawsuits early in the
litigation while, at the same time, ensuring that plaintiffs with meritorious claims
will have their day in court. The Legislature enacted the Patients First Act in 2004,
which supplemented the AOM statute by including additional requirements for a
plaintiff’s AOM in a medical malpractice case. The basic idea behind N.J.S.A.
2A:53A-41 is that the individual who executes the AOM in a medical malpractice
case “be equivalently-qualified to the defendant physician.” Buck, 207 N.J. at 389.
Thus, N.J.S.A. 2A:53A-41 adds to the AOM statute the “equivalently qualified”
requirement -- known as the “kind-for-kind” rule -- for an AOM in a medical
malpractice case, and it recognizes three categories of credentialed physicians for
purposes of that requirement. As relevant here, for those physicians who are
specialists in a field recognized by the American Board of Medical Specialties and
who are board certified in that specialty, the challenging expert must either be
credentialed by a hospital to treat the condition at issue or be board certified in the
same specialty in the year preceding the occurrence that is the basis for the claim or
action. N.J.S.A. 2A:53A-41(a)(1) to (2). (pp. 14-18)

2. In Buck, the defending physician, alleged by the plaintiff to have negligently
prescribed a sleep medication, was board certified in emergency medicine and was
practicing as a family-medicine specialist at the time he treated the plaintiff. 207
N.J. at 382-83. The plaintiff provided an AOM from a specialist in emergency
2
medicine and an AOM from a psychiatrist, but nothing from a family medicine
practitioner. Id. at 382. The trial judge found that the treatment did not involve
emergency medicine and that the psychiatrist’s AOM was insufficient. Id. at 387.
The Appellate Division affirmed. Id. at 383. The Court remanded the matter to the
trial judge to conduct a Ferreira “conference and decide anew the adequacy of [the]
plaintiff’s [AOMs].” Id. at 393, 395. The Court provided guidance -- which was not
dicta -- germane to when a defending physician practices in more than one specialty
and when the treatment involved may fall within those specialty areas. Id. at 387,
391, 393-96. First, the Court stated that “[a] physician may practice in more than
one specialty, and the treatment involved may fall within that physician’s multiple
specialty areas. In that case, an [AOM] from a physician specializing in either area
will suffice.” Id. at 391. Second, the Court directed that a defending physician
“include in his answer the field of medicine in which he specialized, if any, and
whether his treatment of the plaintiff involved that specialty.” Id. at 396. In light of
that direction, now mandated by Rule 4:5-3, there is generally no need for a Ferreira
judge or motion judge to make findings of fact about a physician’s specialty and
whether treatment of the plaintiff involved that specialty because the defending
physician’s Specialty Statement generally resolves those questions. (pp. 18-21)

3. Here, it is undisputed that Dr. Goyal is board certified in the specialty of internal
medicine and in the subspecialty of gastroenterology. The plain language of
N.J.S.A. 2A:53A-41 does not require an AOM to be from an individual with the
same numerous specialties as the defending physician; instead, it requires only the
same “specialty or subspecialty” in the singular. And Dr. Goyal’s “care or treatment
at issue” involves his “specialty or subspecialty” of internal medicine and
gastroenterology, as stated in his Specialty Statement. Thus, as to the threshold
issue of whether plaintiffs’ AOM is sufficient to survive a motion to dismiss, Dr.
Goyal’s Specialty Statement and his later certification verify that his treatment of
Carden involved his medical specialties of internal medicine and gastroenterology.
Under Buck, when “the treatment involved may fall within [a] physician’s multiple
specialty areas” -- as is the case here -- “an [AOM] from a physician specializing in
either area will suffice.” 207 N.J. at 391. Dr. Fitzgibbons’ AOM complies with the
AOM statute, N.J.S.A. 2A:53A-41(a)(2)(a), and Buck, neither of which require an
AOM from an individual matching all areas of practice if a defending physician
practices in multiple specialty areas. Accordingly, the trial judge correctly denied
defendants’ motions. Plaintiffs must still demonstrate Dr. Goyal’s professional
negligence at trial. The Court reviews relevant standards. (pp. 21-28)

REVERSED and REMANDED for further proceedings.

CHIEF JUSTICE RABNER and JUSTICES PATTERSON, PIERRE-LOUIS,
WAINER APTER, NORIEGA, and HOFFMAN join in JUSTICE FASCIALE’s
opinion.
3
SUPREME COURT OF NEW JERSEY
A-43 September Term 2023
089441

Earneka Wiggins and Lynda Myers,
as administratrixes of the estate of
April Carden, deceased,

Plaintiffs-Appellants,

v.

Hackensack Meridian Health, d/b/a
JFK University Medical Center,

Defendant-Respondent,

and

Alok Goyal, M.D., and South
Plainfield Primary Care,

Defendants-Respondents.

On appeal from the Superior Court,
Appellate Division, whose opinion is reported at
478 N.J. Super. 355 (App. Div. 2024).

Argued Decided
November 4, 2024 January 22, 2025

Roshan D. Shah argued the cause for appellants Earneka
Wiggins and Lynda Myers (Shah Law Group, and Lopez
McHugh, attorneys; Roshan D. Shah and Michael S.
Katz, on the brief).

1
Richard J. Tamn argued the cause for respondents Alok
Goyal, M.D., and South Plainfield Primary Care
(Krompier & Tamn, attorneys; Richard J. Tamn, of
counsel and on the brief, and Jason M. Altschul, on the
brief).

Katelyn E. Cutinello argued the cause for respondent
Hackensack Meridian Health d/b/a JFK University
Medical Center (Cocca & Cutinello, attorneys; Katelyn
E. Cutinello and Anthony Cocca, of counsel and on the
briefs).

Christina Vassiliou Harvey argued the cause for amicus
curiae New Jersey Association for Justice (Lomurro
Munson, attorneys; Christina Vassiliou Harvey and
Jonathan H. Lomurro, of counsel and on the brief).

JUSTICE FASCIALE delivered the opinion of the Court.

In this medical malpractice appeal, the legal question is whether

plaintiffs’ service of an affidavit of merit (AOM) from a board-certified

internal medicine doctor is sufficient to overcome a motion to dismiss when

defendants’ Rule 4:5-3 Specialty Statement states that “[a]t all relevant times,

these defendants practiced the medical specialties of Internal Medicine and

Gastroenterology and their treatment of [the patient] involved the medical

specialties of Internal Medicine and Gastroenterology.”

Applying N.J.S.A. 2A:53A-26 to -29 (AOM statute), the New Jersey

Medical Care Access and Responsibility and Patients First Act (Patients First Act),

N.J.S.A. 2A:53A-37 to -42, and Buck v. Henry, 207 N.J. 377 (2011), we hold that

2
when a defending physician practices in more than one specialty and the treatment

involved falls within any of that physician’s specialty areas, then an AOM

from a physician specializing in one of those specialties is sufficient under the

statutes.

Plaintiffs submitted an AOM from a board-certified internist. The

defending physician is also a board-certified internist whose treatment

“involved the medical specialties of Internal Medicine and Gastroenterology,”

according to the Specialty Statement. Service of the AOM from the board-

certified internist should have defeated defendants’ dismissal motions.

Consistent with the purposes of the AOM statute, defeating such motions

ensures that plaintiffs with meritorious claims will have their day in court.

Although plaintiffs here have overcome dismissal at this early stage, they are

still left to their trial proofs.

We therefore reverse the Appellate Division’s judgment and uphold the

orders denying defendants’ motions to dismiss the complaint and motions for

reconsideration.

I.

Earneka Wiggins and Lynda Myers (plaintiffs), in their capacity as

administrators of the Estate of April Carden, filed a medical malpractice

complaint in Essex County and named as defendants Hackensack Meridian

3
Health d/b/a JFK University Medical Center (JFK), Alok Goyal, M.D., and

South Plainfield Primary Care (SPPC) (collectively, defendants).

Specifically, plaintiffs alleged that in 2016, Carden experienced a severe

allergic reaction to “Tramadol and/or Allopurinol” and received a subsequent

diagnosis of Stevens-Johnson Syndrome (SJS). 1 Dr. Goyal prescribed the

Tramadol, and another doctor prescribed the Allopurinol. Carden then

received medical treatment at JFK for her reaction to those drugs.

In 2020, Carden fell and was taken to JFK. Although JFK records noted

an allergy to Tramadol, the “Emergency Department notes and subsequent

consult reports indicated that Carden had no known allergies.” Doctors

diagnosed Carden with a blood clot and then discharged her from JFK. The

next day, Dr. Goyal prescribed Allopurinol for Carden, which plaintiffs

alleged again caused SJS and required readmission to JFK. She remained at

JFK for about ten days. After being transferred to a burn center, Carden

passed away from “cardiopulmonary arrest due to multiple organ failure,

bacteremia, and [SJS].”

1
Stevens-Johnson Syndrome is a disorder most often caused by an adverse
drug reaction; it “causes painful blisters and lesions on the skin and mucous
membranes and can cause severe eye problems.” Esen Karamursel Akpek,
M.D., Stevens-Johnson Syndrome, Johns Hopkins Med.,
https://www.hopkinsmedicine.org/health/conditions-and-diseases/stevens-
johnson-syndrome (last visited Jan. 13, 2025).
4
Plaintiffs alleged that defendants deviated from “generally accepted

standards” by prescribing Allopurinol, which was contraindicated; failing to

take Carden’s proper medical history; failing to diagnose, treat, prevent, and

limit Carden’s injuries; and failing to prescribe prophylactic medications,

obtain necessary consults, and maintain and render medical care. Plaintiffs

further alleged that Carden’s death was “directly attributable to the

Allopurinol,” that Dr. Goyal’s negligence caused Carden’s death, and that JFK

and SPPC were vicariously liable because Dr. Goyal was an “agent, servant, or

employee” of both.

On September 21, 2022, Dr. Goyal and SPPC filed their answer and

included the following Rule 4:5-3 Specialty Statement: “At all relevant times,

these defendants practiced the medical specialties of Internal Medicine and

Gastroenterology and their treatment of [Carden] involved the medical

specialties of Internal Medicine and Gastroenterology.” Dr. Goyal and SPPC’s

answer stated they were without knowledge or information sufficient to form a

belief as to the truth of plaintiffs’ factual allegations. On October 4, 2022,

JFK filed its answer, likewise indicating that it lacked information sufficient to

admit or deny the factual allegations. The sixty-day deadline for service of

AOMs was November 20, 2022.

5
On November 10, 2022, plaintiffs provided each defendant with an

AOM from Dr. Stella Jones Fitzgibbons, who is board certified by the

American Board of Internal Medicine. In the AOM, Dr. Fitzgibbons certified

that she was a “licensed physician . . . for a period in excess of five years

specializing in the field of internal medicine”; that “[a]t the time of the

occurrence that is the basis for the action in this case” she “specialized in the

field of internal medicine”; that “during the year immediately preceding the

date of the occurrence [she] devoted a majority of [her] professional time to

the active clinical practice of internal medicine”; that she had “no financial

interest in the outcome of [this] case”; and that “there is a reasonable

probability that the care, skill or knowledge exercised or exhibited in the

treatment, practice or work of [defendants] fell outside professional treatment

standards.” Five days later, counsel for Dr. Goyal and SPPC objected to the

AOM, stated that Dr. Fitzgibbons was unqualified to execute an AOM as to

them, and requested a timely AOM “by a qualified physician.” About a week

later, JFK’s counsel agreed with that position and noted that plaintiffs’ claims

against JFK were “premised on vicarious liability and/or apparent authority for

Dr. Goyal.”

6
Counsel appeared at a Ferreira conference 2 on November 28, 2022.

Defendants’ counsel explained that Dr. Fitzgibbons was unqualified because

unlike Dr. Goyal, she was board certified in only internal medicine rather than

in both internal medicine and gastroenterology, and because Dr. Fitzgibbons’

medical practice had been limited to internal medicine. Amplifying his

Specialty Statement, Dr. Goyal certified on December 12, 2022, that “[a]ll

treatment that I rendered to [Carden] was provided as both an internist and as a

gastroenterologist.” He added, “[f]or example, my care and treatment of

[Carden] included discussing, recommending and performing colonoscopies

and esophagogastroduodenoscopy, as well as evaluating [Carden] for concerns

such as rectal bleeding and black stool.” 3 Dr. Goyal’s certification is silent as

to prescribing Allopurinol. The Ferreira judge directed defendants to file

motions. 4

2
Ferreira v. Rancocas Orthopedic Assocs., 178 N.J. 144, 154-55 (2003)
(requiring a case management conference to “be held within ninety days of the
service of an answer in all malpractice actions” to address discovery issues and
compliance with the AOM statute and case law).
3
The complaint does not specifically allege that Carden passed away from
treatment related to colonoscopies, an esophagogastroduodenoscopy, rectal
bleeding, or black stool. Instead, it alleges that her death was “directly
attributable to the Allopurinol.”
4
Plaintiffs’ counsel asserted that the Ferreira judge directed Dr. Goyal to
certify whether he prescribed Allopurinol in his capacity as a

7
On December 21, 2022, Dr. Goyal and SPPC filed their motion to

dismiss the complaint for failure to comply with the AOM statute. 5

Responding to plaintiffs’ counsel’s inquiry about whether Dr. Goyal

prescribed Allopurinol in his “capacity as a gastroenterologist,” counsel for

Dr. Goyal stated:

Dr. Goyal’s [December 12, 2022] [c]ertification
remains sufficient . . . as it remains unclear at this
juncture whether Dr. Goyal even prescribed
[A]llopurinol to [Carden]. We have not received the
records from the hospital yet. It would be wholly
improper for Dr. Goyal to execute any affidavit or
certification asserting that he prescribed [A]llopurinol
to [Carden] in any context without having any record
that he in fact prescribed the medication. Nevertheless,
as indicated by his [December 12, 2022] [c]ertification,
Dr. Goyal remain[s] able to certify as to the scope of
his practice in treating [Carden].

[(emphases added).]

JFK filed a cross-motion seeking the same relief. Plaintiffs opposed those

motions.

gastroenterologist. Counsel for Dr. Goyal and SPPC contends that the Ferreira
judge directed Dr. Goyal to certify that his “treatment involved
gastroenterology.” There is no transcript of the Ferreira conference.
5
The next day, a judge granted JFK’s motion to transfer the matter to Union
County.
8
Plaintiffs argued that internists prescribe Allopurinol, not

gastroenterologists. Dr. Fitzgibbons submitted a certification dated December

22, 2022, emphasizing that she was “aware of no known gastrointestinal

condition that is treated by [A]llopurinol.” Dr. Fitzgibbons certified that

Carden’s medical records reflect she “was prescribed [A]llopurinol to treat

high uric acid levels,” which according to Dr. Fitzgibbons “is not related to the

gastrointestinal system.” Dr. Fitzgibbons also certified that “[h]igh uric acid

levels can cause gout or kidney stones, neither of which are gastrointestinal

conditions.” Plaintiffs’ counsel had three other gastroenterologists review the

action, and they concurred that this was not a case for a gastroenterology

expert. 6

Alternatively, plaintiffs argued that Dr. Fitzgibbons was qualified to

execute the AOM and that, given defendants’ Specialty Statement, an AOM

from an internist is sufficient. (relying on Buck, 207 N.J. at 391 (“A physician

may practice in more than one specialty, and the treatment involved may fall

6
Todd Eisner, M.D. (“I am familiar with the prescribing of [A]llopurinol and
am aware of no known gastrointestinal condition that is treated by
[A]llopurinol.”); Stuart Finkel, M.D. (“[T]here [does] not appear to be any
[g]astrointestinal issues for me to consider.”); and Bruce Salzburg, M.D.
(“[T]here does not appear to be any [gastroenterology] issues.”). Plaintiffs’
counsel certified that Dr. Salzburg made that statement to him after reviewing
the action because Dr. Salzburg was unable to provide a certification of his
own. Dr. Eisner provided a certification, and Dr. Finkel provided an affidavit.
9
within that physician’s multiple specialty areas. In that case, an [AOM] from a

physician specializing in either area will suffice.”)).

The trial judge denied the motions to dismiss the complaint. He found

“that the ‘care and treatment at issue’ was the prescribing of Allopurinol, and

the ‘care or treatment at issue involves internal [medicine].’” (citing N.J.S.A.

2A:53A-41). But without the need to make that factual finding and relying on

Buck, the trial judge concluded alternatively that plaintiffs complied with the

AOM statute by submitting the AOM from Dr. Fitzgibbons, who is board

certified in internal medicine.

Defendants moved for reconsideration. Dr. Goyal and SPPC submitted a

certification by Meyer N. Solny, M.D., who is board certified in internal

medicine and gastroenterology. Although the motion record remained unclear

about whether Dr. Goyal prescribed Allopurinol, Dr. Solny certified “that there

certainly is a use for Allopurinol in gastroenterology,” that gastroenterologists

“regularly prescribe Allopurinol,” and that “it is not possible to bifurcate and

segregate my knowledge as a gastroenterologist from that as an internist.”

Defendants also asserted that the trial judge misplaced reliance on Buck. The

judge denied reconsideration.

The Appellate Division granted defendants’ motion for leave to appeal

from the orders denying their motions to dismiss and for reconsideration.

10
Reversing those orders, the appellate court disagreed with the trial judge and

stated that the law instead required plaintiffs to “serve an AOM from a

physician board certified in each of [Dr. Goyal’s] specialties.” Wiggins v.

Hackensack Meridian Health, 478 N.J. Super. 355, 358 (App. Div. 2024). The

Appellate Division concluded that the trial judge erred in resolving factual

disputes about the treatment rendered. Id. at 371. And it determined that the

language in Buck on which plaintiffs and the trial judge relied “was dicta and

not controlling in the circumstances presented here.” 7 Id. at 373.

We granted plaintiffs’ motion for leave to appeal. 258 N.J. 164 (2024).

We also granted the New Jersey Association for Justice (NJAJ) leave to appear

as amicus curiae.

II.

Plaintiffs argue that the Appellate Division misapplied our instruction in

Buck that when a physician practices “in more than one specialty, and the

treatment involved may fall within that physician’s multiple specialty areas . . .

an [AOM] from a physician specializing in either area will suffice.” (quoting

7
The appellate court remanded to address whether plaintiffs were entitled to a
waiver under N.J.S.A. 2A:53A-41(c), which permits waiver from the Patients
First Act under certain circumstances. Wiggins, 478 N.J. Super. at 376. We
need not address whether those circumstances are present because Dr.
Fitzgibbons’ AOM complied with plaintiffs’ obligations under the law.

11
207 N.J. at 391). Plaintiffs contend the appellate court incorrectly reasoned

that this Court’s decision in Nicholas v. Mynster, 213 N.J. 463 (2013), and the

Appellate Division’s recent holding in Pfannenstein v. Surrey, 475 N.J. Super.

83 (App. Div. 2023), supported its judgment. And finally, they assert that

requiring plaintiffs to serve an AOM from a physician who is board certified in

each of Dr. Goyal’s specialties is inconsistent with the AOM statute’s dual

purposes.

Defendants contend that the Appellate Division thoroughly analyzed

Buck, which they argue is distinguishable, and further assert that the language

in Buck on which plaintiffs rely is dicta and not controlling. Defendants

maintain that Nicholas and Pfannenstein provide guidance on the application

of the Patients First Act’s kind-for-kind requirement, requiring an AOM from

an “equivalently qualified physician,” and Buck. Finally, they argue that

dismissal of plaintiffs’ complaint is consistent with the purposes of the AOM

statute and that the appellate court’s judgment is consistent with long-standing

tort principles. 8

8
We need not discuss defendants’ additional contention that we should
address the Appellate Division’s remand. Here, Dr. Fitzgibbons’ AOM was
sufficient to defeat the motions to dismiss. Therefore, the waiver principles of
N.J.S.A. 2A:53A-41(c) are moot.
12
The NJAJ emphasizes that under the AOM statute, N.J.S.A. 2A:53A-41,

and Buck, the trial judge correctly denied defendants’ motions to dismiss and

for reconsideration. Alternatively, NJAJ argues that the standard announced in

Brill v. Guardian Life Insurance Co., 142 N.J. 520, 540 (1995), 9 should apply

to the disputed question of whether Dr. Goyal prescribed Allopurinol and if so,

whether he did so as an internist, gastroenterologist, or both. NJAJ argues that

plaintiffs are entitled to reasonable inferences that the alleged malpractice

“falls within internal medicine.”

III.

We review a trial court’s construction of a statute de novo. Libertarians

for Transparent Gov’t v. Cumberland County, 250 N.J. 46, 55 (2022). In that

inquiry, we look to the Legislature’s intent as expressed in the statute’s plain

terms. Id. at 54 (citing DiProspero v. Penn, 183 N.J. 477, 492-93 (2005)). We

9
In Brill, this Court held,

[u]nder this new standard, a determination whether
there exists a “genuine issue” of material fact that
precludes summary judgment requires the motion judge
to consider whether the competent evidential materials
presented, when viewed in the light most favorable to
the non-moving party, are sufficient to permit a rational
factfinder to resolve the alleged dispute in favor of the
non-moving party.

[142 N.J. at 540.]
13
also review de novo a trial court’s interpretation of a court rule, using

“ordinary principles of statutory construction to interpret the court rule[].”

DiFiore v. Pezic, 254 N.J. 212, 228 (2023) (quoting State v. Robinson, 229

N.J. 44, 67 (2017)).

IV.

In 1995, the AOM statute was one of several bills passed as part of a tort

reform package that balanced “a person’s right to sue and controlling nuisance

suits.” Ferreira v. Rancocas Orthopedic Assocs., 178 N.J. 144, 149 (2003)

(quoting Palanque v. Lambert-Woolley, 168 N.J. 398, 404 (2001)). Under

N.J.S.A. 2A:53A-27, a medical malpractice plaintiff must show that the

complaint is meritorious by obtaining an affidavit from “an appropriate

licensed person” attesting to the “reasonable probability” of professional

negligence. The affidavit must be provided to the defendant within sixty days

of the filing of the answer or, for good cause shown, within an additional

sixty-day period. N.J.S.A. 2A:53A-27. A “plaintiff’s failure to serve the

affidavit within 120 days of the filing of the answer is considered tantamount

to the failure to state a cause of action, subjecting the complaint to dismissal

with prejudice.” Ferreira, 178 N.J. at 150 (citing N.J.S.A. 2A:53A-29). The

dual purposes of the AOM statute are “to weed out frivolous lawsuits early in

the litigation while, at the same time, ensuring that plaintiffs with meritorious

14
claims will have their day in court.” Id. at 150 (quoting Hubbard v. Reed, 168

N.J. 387, 395 (2001)).

The Legislature enacted the Patients First Act in 2004, which

supplemented the AOM statute by including additional requirements for a

plaintiff’s AOM in a medical malpractice case. See L. 2004, c. 17, § 7

(codified at N.J.S.A. 2A:53A-41). The basic idea behind N.J.S.A. 2A:53A-41

is that the individual who executes the AOM in a medical malpractice case

“‘be equivalently-qualified to the defendant’ physician.” Buck, 207 N.J. at

389 (quoting Ryan v. Renny, 203 N.J. 37, 52 (2010)); see also N.J.S.A.

2A:53A-27 (amended concurrently with the enactment of the Patients First

Act, see L. 2004, c. 17, § 8, to specify that, “[i]n the case of an action for

medical malpractice, the person executing the affidavit shall meet the

requirements of a person who provides expert testimony or executes an

affidavit as set forth in [N.J.S.A. 2A:53A-41].”). Thus, N.J.S.A. 2A:53A-41

adds to the AOM statute the “equivalently qualified” requirement for an AOM

in a medical malpractice case. See Buck, 207 N.J. at 392 (“The 2004

amendments to the [AOM] statute added an extra level of complexity to the

obligations placed on plaintiffs’ attorneys . . . .”). The “equivalently

qualified” requirement is known as the “kind-for-kind” rule. See id. at 389.

15
N.J.S.A. 2A:53A-41 recognizes three categories of credentialed

physicians embodying the kind-for-kind rule:

(1) those who are specialists in a field recognized by
the American Board of Medical Specialties (ABMS)
but who are not board certified in that specialty; (2)
those who are specialists in a field recognized by the
ABMS and who are board certified in that specialty;
and (3) those who are “general practitioners.”

[Ibid.; see also N.J.S.A. 2A:53A-41(a), (b).]

As to the first two categories and pertinent to the issues on appeal, N.J.S.A.

2A:53A-41(a) provides in part that,

[i]n an action alleging medical malpractice, a person
shall not . . . execute an affidavit pursuant to the
provisions of [the AOM statute] on the appropriate
standard of practice or care unless the person is licensed
as a physician . . . and meets the following criteria:

a. If the party against whom or on whose behalf the
testimony is offered is a specialist or subspecialist
. . . and the care or treatment at issue involves that
specialty or subspecialty . . . , the person providing
the testimony shall have specialized at the time of
the occurrence that is the basis for the action in the
same specialty or subspecialty, . . . , as the party
against whom or on whose behalf the testimony is
offered, and if the person against whom or on
whose behalf the testimony is being offered is
board certified and the care or treatment at issue
involves that board specialty or subspecialty . . . ,
the expert witness shall be:

16
(1) a physician credentialed by a hospital to
treat patients for the medical condition, or to
perform the procedure, that is the basis for the
claim or action; or

(2) a specialist or subspecialist . . . who is
board certified in the same specialty or
subspecialty, . . . , and during the year
immediately preceding the date of the
occurrence that is the basis for the claim or
action, shall have devoted a majority of his
professional time to either:

(a) the active clinical practice of the same
health care profession in which the
defendant is licensed, and, if the defendant
is a specialist or subspecialist . . . , the
active clinical practice of that specialty or
subspecialty . . . ; or

(b) the instruction of students . . . in the
same health care profession in which the
defendant is licensed . . . and, if that party
is a specialist or subspecialist . . . , in the
same specialty or subspecialty . . . ; or

(c) both.

[N.J.S.A. 2A:53A-41 (emphases added).]

Thus, when a defending physician is a “specialist or subspecialist”

recognized by the ABMS, and the “care or treatment at issue involves that

specialty or subspecialty,” the challenging expert shall have specialized in the

same “specialty or subspecialty.” N.J.S.A. 2A:53A-41(a).

17
Similarly, when a defending physician “practices in an ABMS specialty”

and “is board certified in that specialty” (like here), “the challenging expert

must have additional credentials.” Nicholas, 213 N.J. at 482. For those

physicians who are specialists in a field recognized by the ABMS and who are

board certified in that specialty, the challenging expert “must either be

credentialed by a hospital to treat the condition at issue, N.J.S.A. 2A:53A-

41(a)(1) . . . , or be board certified in the same specialty in the year preceding

‘the occurrence that is the basis for the claim or action,’ N.J.S.A. 2A:53A-

41(a)(2).” Ibid.

In Buck, the defending physician, alleged by the plaintiff to have

negligently prescribed a sleep medication, was board certified in emergency

medicine and was practicing as a family-medicine specialist at the time he

treated the plaintiff. 207 N.J. at 382-83. There was no Ferreira conference.

Id. at 382. The plaintiff provided an AOM from a specialist in emergency

medicine and an AOM from a psychiatrist, but nothing from a family medicine

practitioner. Ibid. Granting summary judgment to the defendant, the trial

judge found that the treatment did not involve emergency medicine and that

the psychiatrist’s AOM was insufficient. Id. at 387. The Appellate Division

affirmed. Id. at 383.

18
On leave to appeal in Buck, this Court stated, as a preliminary matter,

that “[t]his case is a reminder of the important role that Ferreira conferences

play in ensuring that the [AOM] statute fulfills its objective of weeding out

unmeritorious cases rather than worthy ones.” Id. at 393. Additionally, this

Court did not resolve whether the plaintiff’s AOMs were sufficient. Id. at 395.

Instead, this Court remanded and directed the trial judge to conduct a Ferreira

“conference and decide anew the adequacy of [the] plaintiff’s [AOMs].” Ibid.

Recognizing that the trial judge in Buck had sorted out the field of

medicine and the treatment at the summary judgment stage rather than the

Ferreira conference, this Court provided carefully considered guidance,

binding on the lower courts, germane to when a defending physician practices

in more than one specialty and when treatment involved may fall within those

specialty areas. Id. at 387, 391, 393-96. “[M]atters in the opinion of a higher

court which are not decisive of the primary issue presented but which are

germane to that issue . . . are not dicta, but binding decisions of the court.” 5

Am. Jur. 2d Appellate Review § 520 (2024); see also State v. Dabas, 215 N.J.

114, 136-37 (2013) (“Appellate and trial courts consider themselves bound by

this Court’s pronouncements, whether classified as dicta or not.”); State v.

Rose, 206 N.J. 141, 183 (2011) (“[T]he legal findings and determinations of a

19
high court’s considered analysis must be accorded conclusive weight by lower

courts. Our courts have consistently followed this rule.” (footnote omitted)).

First, applying N.J.S.A. 2A:53A-41, the Buck Court explained that the

initial inquiry must be whether the defending physician is a specialist or a

general practitioner. 207 N.J. at 391. If the defending physician is a

specialist, the next inquiry is whether the basis of the malpractice action

“involves” the physician’s specialty. Ibid. In the context of those inquiries,

and particularly as to compliance with the AOM statute and kind-for-kind

requirement contemplated by N.J.S.A. 2A:53A-41, this Court stated, “[a]

physician may practice in more than one specialty, and the treatment involved

may fall within that physician’s multiple specialty areas. In that case, an

[AOM] from a physician specializing in either area will suffice.” Ibid.

Second, to ensure future compliance with the AOM statute and N.J.S.A.

2A:53A-41, the Court directed that a defending physician “include in his

answer the field of medicine in which he specialized, if any, and whether his

treatment of the plaintiff involved that specialty.” Id. at 396. Responding to

the Buck Court’s directive, the Civil Practice Committee proposed amending

Rule 4:5-3, which this Court adopted. The amended rule, effective September

2012, states in part that “[a] physician defending against a malpractice claim

who admits to treating the plaintiff must include in his or her answer the field

20
of medicine in which he or she specialized at that time, if any, and whether his

or her treatment of the plaintiff involved that specialty.” R. 4:5-3.

Thus, there is generally no need for a Ferreira judge or motion judge to

conduct a miniature hearing, take testimony, and make findings of fact about a

physician’s specialty and whether his treatment of the plaintiff involved that

specialty. And judges need not apply Brill on motions to dismiss for failure to

comply with the AOM statute regarding “the field of medicine in which the

[physician is] specialized, if any, and whether his treatment of the plaintiff

involved that specialty” because the defending physician’s Rule 4:5-3

Specialty Statement generally resolves those factual questions.

V.

Application of those legal principles to the facts of this case is

straightforward.

The text of N.J.S.A. 2A:53A-41 is clear. In an action alleging medical

malpractice against a board-certified physician who is a “specialist or

subspecialist” recognized by the ABMS, and when the “care or treatment at

issue involves that specialty or subspecialty,” the person executing the AOM

must likewise be a board-certified “specialist or subspecialist” in the same

“specialty or subspecialty” recognized by the ABMS as the defending

physician. N.J.S.A. 2A:53A-41(a). A majority of the affiant’s professional

21
time “during the year immediately preceding the date of the occurrence that is

the basis for the claim or action” must be devoted to the “active clinical

practice” of the defending physician’s “specialty or subspecialty.” Id. at

(a)(2)(a).

It is undisputed that Dr. Goyal is board certified in the specialty of

internal medicine and in the subspecialty of gastroenterology. N.J.S.A.

2A:53A-41(a) requires the affiant of the AOM to be board certified in the same

“specialty or subspecialty” of the defending physician, not specialties or

subspecialties. N.J.S.A. 2A:53A-41(a)(2)(a) requires the affiant of the AOM

to devote a majority of that person’s “active clinical practice” to the defending

physician’s “specialty or subspecialty,” not specialties or subspecialties. Dr.

Fitzgibbons meets those requirements. The plain language of N.J.S.A.

2A:53A-41 does not require an AOM to be from an individual with the same

numerous specialties as the defending physician; instead, it requires only the

same “specialty or subspecialty” in the singular (emphasis added). 10

N.J.S.A. 2A:53A-41(a) also requires that the “care or treatment at issue

involve[] [the defending physician’s] specialty or subspecialty,” not specialties

10
At oral argument, when counsel for Dr. Goyal and SPPC was asked if the
statute required an affiant to have the same multiple specialties as the
defending physician, counsel conceded that there was no language in the
statute imposing that requirement.
22
or subspecialties. Dr. Goyal’s Specialty Statement verified that his treatment

of Carden involved his medical specialties of internal medicine and

gastroenterology. And his December 2022 certification, which amplified the

Specialty Statement, stated, “[a]ll treatment that I rendered to [Carden] was

provided as both an internist and gastroenterologist.”

Dr. Goyal provided those statements in response to plaintiffs’ detailed

allegations. The complaint expressly alleged that “[Carden]’s death was

directly attributable to the Allopurinol.” The “care or treatment at issue”

involves prescribing Allopurinol. Therefore, under N.J.S.A. 2A:53A-41(a), for

purposes of the sufficiency of the AOM, Dr. Goyal’s “care or treatment at

issue” involves his “specialty or subspecialty” of internal medicine and

gastroenterology, as stated in his Specialty Statement.

At the Ferreira conference and during the motions, the parties debated

whether Dr. Goyal treated Carden as an internist, a gastroenterologist, or both.

Plaintiffs argued that he prescribed Allopurinol as an internist. After the

Ferreira conference, Dr. Goyal’s counsel stated, “it remains unclear at this

juncture whether Dr. Goyal even prescribed [A]llopurinol to [Carden],” since

23
he had not seen JFK’s records. 11 Instead, his counsel relied generally on Dr.

Goyal’s certification, in which he admitted to having treated Carden as an

internist and as a gastroenterologist. Indeed, on reconsideration, Dr. Goyal

submitted Dr. Solny’s certification, who opined “that there certainly is a use

for Allopurinol in gastroenterology,” that gastroenterologists “regularly

prescribe Allopurinol,” and that, as someone “Board Certified in both internal

medicine and gastroenterology, it [was] not possible to bifurcate and segregate

[Dr. Solny’s own] knowledge as a gastroenterologist from that as an

internist.” 12

Regardless, as to the threshold issue of whether plaintiffs’ AOM is

sufficient to survive a motion to dismiss, Dr. Goyal’s Specialty Statement and

his later certification verify that his treatment of Carden involved his medical

specialties of internal medicine and gastroenterology. Under Buck, when “the

treatment involved may fall within [a] physician’s multiple specialty areas” --

11
Presumably Dr. Goyal’s own medical records would answer whether he
prescribed Allopurinol from September 4 to September 8, 2020, which
according to the complaint was after JFK discharged Carden.
12
Defendants submitted Dr. Solny’s certification for the first time on
reconsideration and argued generally that gastroenterologists also prescribe
Allopurinol. Dr. Goyal had certified only that “[a]ll treatment that I rendered
to [Carden] was provided as both an internist and as a gastroenterologist.” As
stated earlier, Dr. Goyal’s December 2022 certification was silent about
whether he himself prescribed Allopurinol as an internist, gastroenterologist,
or both, and indeed it did not mention Allopurinol at all.
24
as is the case here -- “an [AOM] from a physician specializing in either area

will suffice.” 207 N.J. at 391 (emphasis added). Therefore, Dr. Fitzgibbons’

AOM complies with the AOM statute, N.J.S.A. 2A:53A-41(a)(2)(a), and Buck,

neither of which require an AOM from an individual matching all areas of

practice if a defending physician practices in multiple specialty areas.

Accordingly, the trial judge correctly denied defendants’ motions.

Our holding that an AOM that falls within any of a defending

physician’s specialties is sufficient comports with the purposes underlying the

AOM statute as previously explained by this Court in Buck. “[T]here is no

legislative interest in barring meritorious claims brought in good faith[.]”

Buck, 207 N.J. at 393 (alterations in original) (quoting Ferreira, 178 N.J. at 50-

51). It is well known that “the Legislature did not intend ‘to create a minefield

of hyper-technicalities in order to doom innocent litigants possessing

meritorious claims.’” Id. at 393-94 (internal quotation marks omitted)

(quoting Ryan, 203 N.J. at 51). At this stage in the case, a plaintiff need only

be guided by a defending physician’s Specialty Statement and provide an

AOM from an individual in one of the specialty areas involved in the

defending physician’s treatment of the plaintiff, not jump through hoops to

25
find an exact match of all specialty practice areas to survive a motion to

dismiss. 13

We disagree with the notion that this Court’s opinion in Nicholas and the

Appellate Division’s decision in Pfannenstein altered Buck. In Nicholas, the

AOMs were executed by physicians who did not meet the kind-for-kind

requirement of N.J.S.A. 2A:53A-41. 213 N.J. at 468. The defending

physicians were board certified in emergency medicine and family medicine.

Id. at 467. The plaintiff submitted AOMs from a physician “Board Certified in

the medical specialty of Internal Medicine, Pulmonary Diseases, Critical Care,

and Undersea & Hyperbaric Medicine,” and from another physician who was

board certified in internal medicine. Id. at 471. And in Pfannenstein, the

defending physicians specialized in internal medicine, but the plaintiff

submitted an AOM from a hematologist. 475 N.J. Super. at 90. Those cases

left untouched our guidance in Buck, which was germane to situations in

which a plaintiff submits an AOM against a defending physician who practices

in multiple specialty areas and the treatment at issue may fall within those

specialty areas. 207 N.J. at 391.

13
Indeed, plaintiffs demonstrated good faith by providing, in further support
of their argument that the AOM from Dr. Fitzgibbons was sufficient, multiple
certifications from physicians to show that Dr. Goyal’s alleged prescription of
Allopurinol was not a gastroenterology issue.
26
VI.

Finally, we once again emphasize that our reversal furthers the

fundamental purposes of the AOM statute, which are “to weed out frivolous

lawsuits early in the litigation while, at the same time, ensuring that plaintiffs

with meritorious claims will have their day in court.” Ferreira, 178 N.J. at 150

(quoting Hubbard, 168 N.J. at 395). Although application of N.J.S.A.

2A:53A-41 and Buck have ensured that this matter will proceed on the merits,

plaintiffs are still left to their proofs. Our holding in no way relieves plaintiffs

from demonstrating Dr. Goyal’s professional negligence at trial; we resolve

only the threshold issue of the sufficiency of plaintiffs’ AOM.

At trial, to prove medical malpractice took place, “a plaintiff must

present expert testimony establishing (1) the applicable standard of care; (2) a

deviation from that standard of care; and (3) that the deviation proximately

caused the injury.” Haviland v. Lourdes Med. Ctr. of Burlington Cnty., Inc.,

250 N.J. 368, 384 (2022) (internal quotation marks omitted) (quoting Nicholas,

213 N.J. at 478). “With rare exception, expert testimony is needed to establish

the standard of care.” Morlino v. Med. Ctr. of Ocean Cnty., 152 N.J. 563, 578

(1998). Jurors cannot guess about the applicable standard of care by which to

judge the alleged negligence of a defending physician. See Model Jury

Charges (Civil), 5.50A, “Duty and Negligence” (approved Mar. 2002). Jurors

27
determine the applicable medical standard from the testimony of experts, and it

is for the jury to resolve any conflict that arises in that testimony. Ibid.

VII.

We therefore reverse the Appellate Division’s judgment, reinstate the

trial court orders denying defendants’ motions to dismiss and motions for

reconsideration, and remand for further proceedings.

CHIEF JUSTICE RABNER and JUSTICES PATTERSON, PIERRE-
LOUIS, WAINER APTER, NORIEGA, and HOFFMAN join in JUSTICE
FASCIALE’s opinion.

28

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/cases/10784949. Public record. Not legal advice.
